SThree PLC - Q1 update

Against a softening macro backdrop, the solidity of SThree’s Q1 net fee outcome; +4% YoY at constant currency (+9% post FX), speaks volumes to the resilience of SThree’s differentiated focus on both Contract (now 81% of net fees) and STEM disciplines. There are a number of moving parts beneath the headlines – Contract growth vs Permanent declines as well as a degree of regional variation – nonetheless the Q1 outcome was consistent with our full year expectations and we leave our estimates unchan

LIBERUM: SThree* - Resilient Q1

LIBERUM: UK Small & Mid Cap Dispatches

LIBERUM: Morning Comment

SThree PLC - FY results

Final results show a performance that was significantly ahead of expectations at the start of the year. SThree also provided a great deal of detail around the technology improvement programme. This significant investment (£26m - £31m over the next two years with £4m already expensed) is a fundamental driver behind SThree’s strategic growth and margin ambitions and could see SThree move beyond a linear relationship between growth and sales headcount.

LIBERUM: SThree* - Bridging to a 21% conversion rate

LIBERUM: SThree* - No FY22 surprises, FY23E on track

LIBERUM: SThree* - Another strong quarter

LIBERUM: SThree* - Charts to back up the thesis

FY22 Financials

Capital Limited (LSE: CAPD) released its full year results (YE Dec 2022) this morning. The company had already released the operational figures for the year including revenue so focus is on EBITDA and below as well guidance. Having said that it is impressive that this is the third consecutive year Capital has delivered material growth in revenue, with full year sales increasing 28%, following 68% YoY growth in 2021 and 18% YoY growth in 2020. Moreover the company is guiding to $320-340m for FY23

Hybridan Small Cap Feast - 21 Feb 23

21 February 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objec

LIBERUM: Luceco* - Margin momentum coming into view

LIBERUM: Yü Group* - Strong momentum and cash flow

LIBERUM: Costain Group* - Free cash more than 50% market cap

Revised forecasts

Judges Scientific FY Results – Outstanding results, Steady organic, M&A delivers in spades

Judges Scientific is a group involved in the buy and build of scientific instrumentation businesses. Testament to the strength of its highly engineered offer and global diversified customer base (offsetting Covid-induced earlier weaker order intake from China, although rebounding in December 2022), total revenue increased an impressive 24% to £113.2m (organic basis 8%), buoyed by Geotek, with adjusted PBT increasing a substantial 56.7% to £28.3m (FY2021: £18.1m), 4% ahead of our estimate of £27

LIBERUM: Judges Scientific* - FY22 ahead of expectations

Supreme plc: disposal of T-Juice intellectual property

Supreme reports that it has entered into an agreement with an associated company of La Vape Professionelle Distribution (LVP), a leading French wholesaler of e-cigarettes and e-liquids, for the disposal of the intellectual property (IP) of T-Juice, inclusive of the Red Astaire brand. Supreme will receive an upfront payment of €4.5m (£3.97m) in respect of T-Juice brand IP, with the addition of income from consultancy services. The agreement ushers in a new strategic partnership in which Supreme

Hardide Update

The AGM statement reiterated the ‘cautious optimism’ that underpinned the group’s recent annual report (covered in our 9 February update). HDD is experiencing growth across all of its key markets; aerospace, energy and industrial products. First half revenues to end March 2023 are expected to come in around 7% ahead y-o-y. That will be sufficient to deliver forecast EBITDA breakeven in FY23 despite deferral of a c. £0.3m order into H1 FY24. That outcome underlines the success of initiatives to

SHORE CAPITAL - Judges Scientific+ (JDG, House Stock at 8,920p)

SP Angel Spec Sits: (YUG) Stellar 2022 Results + New Dividend Policy

YUG announced its full year 2022 financial results, which exceeded recently revised market expectations.

LIBERUM: Kier Group - Continued margin strength

EQTEC (EQT LN) - Italia MDC project operational

Italia MDC project now operational. EQTEC has announced that its Italia MDC project is now operational. The gasification and biochar facilities were commissioned in January, with the Jenbacher engine commissioned in March and first electricity export recently achieved. EQTEC expects full handover of operations before the end of March.

Powerhouse Energy - Irish JV Agreed

Powerhouse has agreed terms for a joint venture to develop a waste to hydrogen project in the Republic of Ireland on a strong-centrally located site. This will now be the company’s entry point into the Irish market. While the country has a plastic recycling rate of 29% it is highly reliant on exporting packaging material abroad for treatment and in-country solutions represent a wider opportunity for Powerhouse in our view.